Avoid the Inappropriate Use of Antipsychotic Medication in Anxiety Disorders
AI Summary
BCBS Texas issued guidance discouraging the inappropriate use of antipsychotic medications for treating anxiety disorders, as most are not FDA-approved for these conditions. The policy emphasizes careful risk-benefit assessment and provides clinical practice guidelines for anxiety disorder treatment.
Action Required
Immediately: Providers prescribing antipsychotic medications for anxiety disorders must document thorough symptom assessment and risk-benefit analysis in patient records. Billing team should flag claims for antipsychotic prescriptions with anxiety disorder diagnoses for documentation review. Ensure diabetes screening is scheduled annually for patients 18-64 with schizophrenia or bipolar disorder on antipsychotic medications.
Plan Types
All Plans
States
TX
Specialties
psychiatry, family-medicine, internal-medicine, pediatrics